Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 14 de 14
Filter
Add more filters










Publication year range
1.
Molecules ; 24(8)2019 Apr 16.
Article in English | MEDLINE | ID: mdl-31014025

ABSTRACT

Snakebite envenoming is a serious medical problem in different areas of the world. In Latin America, the major prevalence is due to snakes of the family Viperidae, where rattlesnakes (Crotalus) are included. They produce hemotoxic venom which causes bleeding, tissue degradation and necrosis. Each venom has several enzymatic activities, producing different effects in the envenoming, doing its clinical effects difficult to study. Comparison between venom molecules is also difficult when different techniques are used, and therefore, their identification/characterization using the same methodology is necessary. In this work, a general biochemical characterization in snake venom of serine proteases (SVSP), phospholipases A2 (PLA2), metalloproteases (SVMP) and hyaluronidases (SVH) of Crotalus aquilus (Ca), Crotalus polystictus (Cp) and Crotalus molossus nigrescens (Cmn) was done. Differences in protein pattern, enzyme content and enzymatic activities were observed. All the venoms showed high PLA2 activity, high molecular weight SVSP, and a wide variety of SVMP and SVH forms. Ca and Cp showed the highest enzymatic activities of SVMP and SVSP trypsin-like and chymotrypsin-like, whereas Cmn showed the highest SVH and similar PLA2 activity with Ca. All the venoms showed peptides with similar molecular weight to crotamine-like myotoxins. No previous biochemical characterization of C. aquilus has been reported and there are no previous analyses that include these four protein families in these Crotalus venoms.


Subject(s)
Hydrolases/metabolism , Hydrolases/toxicity , Snake Venoms/enzymology , Animals , Crotalus , Metalloproteases/analysis , Mexico , Serine Proteases/analysis , Species Specificity
2.
Chem Biol Interact ; 278: 179-188, 2017 Dec 25.
Article in English | MEDLINE | ID: mdl-28989041

ABSTRACT

Arginine auxotrophy constitutes the Achilles' heel for several tumors, among them glioblastoma multiforme (GBM). Hence, arginine-depleting enzymes such as arginine deiminase (ADI) from Streptococcus pyogenes are promising for treatment of primary and maybe even refractory GBM. Based on our previous study in which ADI-susceptibility was shown on a panel of patient-derived GBM cell lines, we here aimed at deciphering underlying molecular mechanisms of ADI-mediated growth inhibition. We found that ADI (35 mU/mL) initially induces a cellular stress-response that is characterized by upregulation of genes primarily belonging to the heat-shock protein family. In addition to autophagocytosis, we show for the first time that senescence constitutes another cellular response mechanism upon ADI-treatment and that this bacterial enzyme is able to act as radiosensitizer (» cases). Long-term treatment schedules revealed no resistance development, with treated cells showing morphological signs of cell stress. Next, several combination strategies were employed to optimize ADI-based treatment. Simultaneous and sequential S. pyogenes ADI-based combinations included substances acting at different molecular pathways (curcumin, resveratrol, quinacrine, and sorafenib, 2 × 72 h treatment). Adding drugs to GBM cell lines (n = 4, including a matched pair of primary and recurrent GBM in one case) accelerated and potentiated ADI-mediated cytotoxicity. Autophagy was identified as the main cause of tumor growth inhibition. Of note, residual cells again showed classical signs of senescence in most combinations. Our results suggest an alternative treatment regimen for this fatal cancer type which circumvents many of the traditional barriers. Using the metabolic defect in GBM thus warrants further (pre-) clinical evaluation.


Subject(s)
Autophagy/drug effects , Bacterial Proteins/toxicity , Cellular Senescence/drug effects , Hydrolases/toxicity , Autophagy/radiation effects , Bacterial Proteins/genetics , Bacterial Proteins/metabolism , Cell Line, Tumor , Cell Survival/drug effects , Cellular Senescence/radiation effects , Curcumin/toxicity , Gamma Rays , Glioblastoma/metabolism , Glioblastoma/pathology , Heat-Shock Proteins/metabolism , Humans , Hydrolases/genetics , Hydrolases/metabolism , Quinacrine/toxicity , Recombinant Proteins/biosynthesis , Recombinant Proteins/isolation & purification , Recombinant Proteins/toxicity , Resveratrol , Stilbenes/toxicity , Streptococcus pyogenes/enzymology , Superoxide Dismutase/metabolism , Up-Regulation/drug effects
3.
Toxicol Lett ; 274: 64-68, 2017 May 15.
Article in English | MEDLINE | ID: mdl-28412453

ABSTRACT

Cyanide is a metabolic poison that inhibits cytochrome c oxidase. Its broad applications in manufacturing and history as an agent of warfare/terror highlight the limitations in approved cyanide antidotes for mass casualties. Sulfanegen, a pre-clinical antidote for cyanide poisoning, exploits an endogenous detoxification pathway and should be amenable to mass-casualty scenarios. Because human studies are unethical, determination of appropriate animal species as models in translational studies for FDA approval under the "Animal Rule" are critical. Here, we compared the specific activities of mercaptopyruvate sulfurtransferase (MST, required for sulfanegen's activity), across common laboratory models of cyanide intoxication, and humans. Human MST activities in erythrocytes (measured as micromole pyruvate/min/106 rbc) were closest to those of Swiss-Webster mice and NZW rabbits. Similar species were selected for a more detailed tissue-specific comparison of MST activities. NZW Rabbits were closest to humans in the liver and kidney mitochondrial fractions, the Swiss-Webster mouse was closest to humans in the liver cytosolic fraction, while C57BL/6 mouse was closest in the kidney cytosolic fraction. These data comparing MST activities in animal models will help justify the use of those specific animals per the animal rule. Interestingly, statistically significant differences were found in MST activities of liver mitochondria between human smokers and non-smokers (p=0.0030).


Subject(s)
Erythrocytes/enzymology , Gene Expression Regulation, Enzymologic/physiology , Sulfurtransferases/metabolism , Animals , Female , Humans , Hydrolases/toxicity , Kidney/enzymology , Liver/enzymology , Male , Species Specificity , Sulfurtransferases/genetics
4.
Cancer Res ; 74(3): 896-907, 2014 Feb 01.
Article in English | MEDLINE | ID: mdl-24285724

ABSTRACT

Targeted therapies have yet to have significant impact on the survival of patients with bladder cancer. In this study, we focused on the urea cycle enzyme argininosuccinate synthetase 1 (ASS1) as a therapeutic target in bladder cancer, based on our discovery of the prognostic and functional import of ASS1 in this setting. ASS1 expression status in bladder tumors from 183 Caucasian and 295 Asian patients was analyzed, along with its hypothesized prognostic impact and association with clinicopathologic features, including tumor size and invasion. Furthermore, the genetics, biology, and therapeutic implications of ASS1 loss were investigated in urothelial cancer cells. We detected ASS1 negativity in 40% of bladder cancers, in which multivariate analysis indicated worse disease-specific and metastasis-free survival. ASS1 loss secondary to epigenetic silencing was accompanied by increased tumor cell proliferation and invasion, consistent with a tumor-suppressor role for ASS1. In developing a treatment approach, we identified a novel targeted antimetabolite strategy to exploit arginine deprivation with pegylated arginine deiminase (ADI-PEG20) as a therapeutic. ADI-PEG20 was synthetically lethal in ASS1-methylated bladder cells and its exposure was associated with a marked reduction in intracellular levels of thymidine, due to suppression of both uptake and de novo synthesis. We found that thymidine uptake correlated with thymidine kinase-1 protein levels and that thymidine levels were imageable with [(18)F]-fluoro-L-thymidine (FLT)-positron emission tomography (PET). In contrast, inhibition of de novo synthesis was linked to decreased expression of thymidylate synthase and dihydrofolate reductase. Notably, inhibition of de novo synthesis was associated with potentiation of ADI-PEG20 activity by the antifolate drug pemetrexed. Taken together, our findings argue that arginine deprivation combined with antifolates warrants clinical investigation in ASS1-negative urothelial and related cancers, using FLT-PET as an early surrogate marker of response.


Subject(s)
Argininosuccinate Synthase/metabolism , Positron-Emission Tomography , Urinary Bladder Neoplasms/diagnosis , Urinary Bladder Neoplasms/metabolism , Animals , Antimetabolites, Antineoplastic/pharmacology , Argininosuccinate Synthase/deficiency , Argininosuccinate Synthase/genetics , Cell Line, Tumor , Cell Proliferation , DNA Methylation , Disease Models, Animal , Drug Synergism , Female , Glutamates/pharmacology , Guanine/analogs & derivatives , Guanine/pharmacology , Humans , Hydrolases/pharmacology , Hydrolases/toxicity , Immunohistochemistry , Mice , Neoplasm Invasiveness , Pemetrexed , Polyethylene Glycols/pharmacology , Polyethylene Glycols/toxicity , Prognosis , Pyrimidines/metabolism , Urinary Bladder Neoplasms/drug therapy , Urinary Bladder Neoplasms/genetics , Urinary Bladder Neoplasms/mortality , X-Ray Microtomography
5.
Biomed Res Int ; 2013: 186068, 2013.
Article in English | MEDLINE | ID: mdl-23936777

ABSTRACT

The aim of our investigation was to characterize the role of group I mGluRs and NMDA receptors in pathomechanisms of experimental autoimmune encephalomyelitis (EAE), the rodent model of MS. We tested the effects of LY 367385 (S-2-methyl-4-carboxyphenylglycine, a competitive antagonist of mGluR1), MPEP (2-methyl-6-(phenylethynyl)-pyridine, an antagonist of mGluR5), and the uncompetitive NMDA receptor antagonists amantadine and memantine on modulation of neurological deficits observed in rats with EAE. The neurological symptoms of EAE started at 10-11 days post-injection (d.p.i.) and peaked after 12-13 d.p.i. The protein levels of mGluRs and NMDA did not increase in early phases of EAE (4 d.p.i.), but starting from 8 d.p.i. to 25 d.p.i., we observed a significant elevation of mGluR1 and mGluR5 protein expression by about 20% and NMDA protein expression by about 10% over the control at 25 d.p.i. The changes in protein levels were accompanied by changes in mRNA expression of group I mGluRs and NMDARs. During the late disease phase (20-25 d.p.i.), the mRNA expression levels reached 300% of control values. In contrast, treatment with individual receptor antagonists resulted in a reduction of mRNA levels relative to untreated animals.


Subject(s)
Excitatory Amino Acid Antagonists/administration & dosage , Multiple Sclerosis/drug therapy , Receptors, Glutamate/biosynthesis , Receptors, N-Methyl-D-Aspartate/metabolism , Amantadine/administration & dosage , Animals , Disease Models, Animal , Encephalomyelitis, Autoimmune, Experimental/chemically induced , Encephalomyelitis, Autoimmune, Experimental/pathology , Female , Gene Expression Regulation , Humans , Hydrolases/administration & dosage , Hydrolases/toxicity , Multiple Sclerosis/genetics , Multiple Sclerosis/pathology , RNA, Messenger/biosynthesis , Rats , Receptors, Glutamate/metabolism
6.
Cell Death Dis ; 3: e342, 2012 Jul 05.
Article in English | MEDLINE | ID: mdl-22764101

ABSTRACT

Tumours lacking argininosuccinate synthetase-1 (ASS1) are auxotrophic for arginine and sensitive to amino-acid deprivation. Here, we investigated the role of ASS1 as a biomarker of response to the arginine-lowering agent, pegylated arginine deiminase (ADI-PEG20), in lymphoid malignancies. Although ASS1 protein was largely undetectable in normal and malignant lymphoid tissues, frequent hypermethylation of the ASS1 promoter was observed specifically in the latter. A good correlation was observed between ASS1 methylation, low ASS1 mRNA, absence of ASS1 protein expression and sensitivity to ADI-PEG20 in malignant lymphoid cell lines. We confirmed that the demethylating agent 5-Aza-dC reactivated ASS1 expression and rescued lymphoma cell lines from ADI-PEG20 cytotoxicity. ASS1-methylated cell lines exhibited autophagy and caspase-dependent apoptosis following treatment with ADI-PEG20. In addition, the autophagy inhibitor chloroquine triggered an accumulation of light chain 3-II protein and potentiated the apoptotic effect of ADI-PEG20 in malignant lymphoid cells and patient-derived tumour cells. Finally, a patient with an ASS1-methylated cutaneous T-cell lymphoma responded to compassionate-use ADI-PEG20. In summary, ASS1 promoter methylation contributes to arginine auxotrophy and represents a novel biomarker for evaluating the efficacy of arginine deprivation in patients with lymphoma.


Subject(s)
Apoptosis/drug effects , Argininosuccinate Synthase/metabolism , Autophagy/drug effects , Caspases/metabolism , Hydrolases/toxicity , Polyethylene Glycols/toxicity , Arginine/metabolism , Argininosuccinate Synthase/genetics , Chloroquine/pharmacology , DNA Methylation , Humans , Hydrolases/therapeutic use , Lymphoma/drug therapy , Lymphoma, T-Cell, Cutaneous/drug therapy , Lymphoma, T-Cell, Cutaneous/pathology , Microtubule-Associated Proteins/metabolism , Polyethylene Glycols/therapeutic use , Promoter Regions, Genetic , Tumor Cells, Cultured
7.
Mol Cancer Ther ; 10(9): 1563-70, 2011 Sep.
Article in English | MEDLINE | ID: mdl-21697396

ABSTRACT

Cancer cells acquire abnormalities in energy metabolism, collectively known as the Warburg effect, affecting substrate availability of thiamine-dependent enzymes. To investigate a strategy to exploit abnormal cancer-associated metabolism related to thiamine, we tested the cytotoxicity of native Bacillus thiaminolyticus thiaminase I enzyme, which digests thiamine, in the NCI60 cell line drug cytotoxicity screening program and found that leukemia cell lines were among the most sensitive to thiaminase I. We obtained additional lymphoid leukemia cell lines and confirmed that native thiaminase I and linear chain PEGylated thiaminase I enzyme (LCPTE) have cytotoxic activity in these cell lines. In addition, the IC(50) of 3 of the 5 leukemia cell lines (Reh, RS4, and Jurkat) were at least 1,000-fold more sensitive than Molt-4 cells, which in turn, were among the most sensitive in the NCI60 panel. The 3 LCPTE-sensitive leukemia cell lines were also sensitive to removal of thiamine from the medium, thus suggesting the mechanism of action of LCPTE involves extracellular thiamine starvation. Surprisingly, rapamycin showed a protective effect against LCPTE toxicity in the 3 LCPTE-sensitive cell lines but not in the other 2 cell lines, suggesting involvement of an mTOR-dependent pathway. Immunoblot analysis of the LCPTE-sensitive cell lines after LCPTE exposure revealed changes in mTOR pathway phosphorylation. Nude mice bearing RS4 leukemia xenografts showed both tumor growth delay and prolonged survival after a single dose of LCPTE. Therefore, disruption of thiamine-dependent metabolism may be a novel therapeutic approach to target altered energy metabolism in leukemia and other cancers.


Subject(s)
Antineoplastic Agents/toxicity , Bacillus/enzymology , Hydrolases/toxicity , Leukemia, Lymphoid/drug therapy , Animals , Antineoplastic Agents/therapeutic use , Cell Line, Tumor , Cell Proliferation/drug effects , Dose-Response Relationship, Drug , Female , HL-60 Cells , Humans , Hydrolases/therapeutic use , Jurkat Cells , Leukemia, Lymphoid/metabolism , Leukemia, Lymphoid/mortality , Mice , Mice, Nude , Recombinant Proteins/therapeutic use , Recombinant Proteins/toxicity , Signal Transduction/drug effects , TOR Serine-Threonine Kinases/metabolism , Thiamine/metabolism , Tumor Burden/drug effects , Xenograft Model Antitumor Assays
8.
J Immunol ; 186(7): 4396-404, 2011 Apr 01.
Article in English | MEDLINE | ID: mdl-21346230

ABSTRACT

Rheumatoid arthritis is associated with the development of autoantibodies to citrullinated self-proteins. Citrullinated synovial proteins, which are generated via the actions of the protein arginine deiminases (PADs), are known to develop in the murine collagen-induced arthritis (CIA) model of inflammatory arthritis. Given these findings, we evaluated whether N-α-benzoyl-N5-(2-chloro-1-iminoethyl)-L-ornithine amide (Cl-amidine), a recently described pan-PAD inhibitor, could affect the development of arthritis and autoimmunity by treating mice in the CIA model with Cl-amidine on days 0-35. Cl-amidine treatment reduced total synovial and serum citrullination, decreased clinical disease activity by ∼50%, and significantly decreased IgG2a anti-mouse type II collagen Abs. Additionally, histopathology scores and total complement C3 deposition were significantly lower in Cl-amidine-treated mice compared with vehicle controls. Synovial microarray analyses demonstrated decreased IgG reactivity to several native and citrullinated epitopes compared with vehicle controls. Cl-amidine treatment had no ameliorative effect on collagen Ab-induced arthritis, suggesting its primary protective mechanism was not mediated through effector pathways. Reduced levels of citrullinated synovial proteins observed in mice treated with Cl-amidine are consistent with the notion that Cl-amidine derives its efficacy from its ability to inhibit the deiminating activity of PADs. In total, these results suggested that PADs are necessary participants in the autoimmune and subsequent inflammatory processes in CIA. Cl-amidine may represent a novel class of disease-modifying agents that modulate aberrant citrullination, and perhaps other immune processes, necessary for the development of inflammatory arthritis.


Subject(s)
Amidines/therapeutic use , Arthritis, Experimental/drug therapy , Arthritis, Experimental/immunology , Enzyme Inhibitors/therapeutic use , Hydrolases/antagonists & inhibitors , Immunosuppressive Agents/therapeutic use , Ornithine/analogs & derivatives , Animals , Arthritis, Experimental/pathology , Arthritis, Rheumatoid/drug therapy , Arthritis, Rheumatoid/immunology , Arthritis, Rheumatoid/pathology , Autoantibodies/biosynthesis , Autoantibodies/toxicity , Citrulline/metabolism , Collagen Type II/antagonists & inhibitors , Collagen Type II/immunology , Hydrolases/toxicity , Male , Mice , Mice, Inbred DBA , Ornithine/therapeutic use , Peptides, Cyclic/immunology , Peptides, Cyclic/metabolism , Protein-Arginine Deiminases , Severity of Illness Index , Synovial Membrane/immunology , Synovial Membrane/metabolism , Synovial Membrane/pathology
9.
Biosci Biotechnol Biochem ; 67(1): 221-4, 2003 Jan.
Article in English | MEDLINE | ID: mdl-12619703

ABSTRACT

We investigated whether a plant chitinase can be used as a biocontrol agent instead of chemical fungicides by spraying chitinase E (family 19; class IV) from a yam (Dioscorea opposita Thunb) alone or together with beta-1,3-glucanase directly onto the surface of a powdery mildew infecting strawberry berries and leaves. Results were observed by eye and with a scanning electron microscope. The powdery mildew infecting the strawberries was degraded, mainly by the chitinase, and the disease did not appear again for more than 2 weeks. These results indicated that this kind of plant chitinase might be safe and biodegradable biocontrol agent for use instead of conventional fungicides.


Subject(s)
Chitinases/toxicity , Dioscorea/enzymology , Fungicides, Industrial , Pest Control, Biological , Chitinases/isolation & purification , Fragaria , Hydrolases/toxicity , Microscopy, Electron, Scanning , Plant Diseases/microbiology
10.
J Nutr ; 130(6): 1625-8, 2000 Jun.
Article in English | MEDLINE | ID: mdl-10827220

ABSTRACT

A fairly high activity of a relatively heat-resistant thiaminase was detected and characterized from the pupae of an African silkworm Anaphe spp. which had been the putative cause of a seasonal ataxia and impaired consciousness in Nigerians. The thiaminase in the buffer extract of Anaphe pupae was type I (thiamin: base 2-methyl-4-aminopyrimidine methyl transferase EC 2.5.1.2), and the optimal temperature and pH were 70 degrees C and 8.0-8.5, respectively. Based on gel filtration chromatography, the molecules were estimated to be 200 kDa. Second substrates which could be utilized by the thiaminase were pyridoxine, amino acids, glutathione, taurine and 4-aminopyridine. Thiamin phosphate esters were inactive as substrates. This is the first report describing an insect thiaminase. Our results indicate the necessity of thorough heat treatment for the detoxification of the African silkworm, making the worm a safe source of high-quality protein.


Subject(s)
Ataxia/etiology , Bombyx/enzymology , Diet/adverse effects , Hydrolases/metabolism , Animals , Ataxia/prevention & control , Chromatography, Gel , Humans , Hydrolases/isolation & purification , Hydrolases/toxicity , Nigeria , Seasons , Substrate Specificity , Thiamine/metabolism
11.
Leukemia ; 14(5): 826-9, 2000 May.
Article in English | MEDLINE | ID: mdl-10803513

ABSTRACT

L-Asparaginase is used for the treatment of acute leukemias, but is sometimes ineffective or associated with severe side-effects. We report here that the enzyme arginine deiminase is approximately 100-fold more potent than L-asparaginase in inhibiting the proliferation of cultured human lymphatic leukemia cell lines while it appears to be less effective in leukemia cells of myeloid origin. The inhibition of cell proliferation involves cell growth arrest in the G1- and/or S-phase and eventually apoptotic cell death. Our results suggest the possibility of a future use of arginine deiminase for the therapy of leukemia.


Subject(s)
Antineoplastic Agents/toxicity , Apoptosis/drug effects , Asparaginase/toxicity , Cell Cycle/drug effects , Cell Division/drug effects , Hydrolases/toxicity , Precursor Cell Lymphoblastic Leukemia-Lymphoma/pathology , Child , HL-60 Cells , Humans , Hydrolases/isolation & purification , Jurkat Cells , Leukemia, B-Cell , Lymphocytes/drug effects , Lymphocytes/pathology , Mycoplasma/enzymology , Precursor Cell Lymphoblastic Leukemia-Lymphoma/blood , Tumor Cells, Cultured
12.
Mol Cell Biol ; 14(2): 1017-25, 1994 Feb.
Article in English | MEDLINE | ID: mdl-8289782

ABSTRACT

k9 killer toxin from Hansenula mrakii was used to select a number of resistant mutants from Saccharomyces cerevisiae. Preliminary biochemical and genetic studies showed that some of them acquired structural defects in the cell wall. One of these mutants, the knr4-1 mutant, displays a number of cell wall defects, including osmotic sensitivity; sensitivity to cercosporamide, a known antifungal agent; and resistance to Zymolyase, a (1,3)-beta-glucanase. We report here the isolation and analysis of the KNR4 gene. DNA sequence analysis revealed an uninterrupted open reading frame which contains five potential start codons. The longest coding template encodes a protein of 505 amino acids with a calculated molecular mass of 57,044 Da. A data base search revealed 100% identity with a nuclear protein, SMI1p. Disruption of the KNR4 locus does not result in cell death; however, it leads to reduced levels of both (1,3)-beta-glucan synthase activity and (1,3)-beta-glucan content in the cell wall. The gene was mapped to the right arm of chromosome VII.


Subject(s)
Drug Resistance, Microbial/genetics , Fungal Proteins/biosynthesis , Genes, Fungal , Glucans/biosynthesis , Glucosyltransferases/biosynthesis , Membrane Proteins , Saccharomyces cerevisiae Proteins , Saccharomyces cerevisiae/genetics , Saccharomyces cerevisiae/metabolism , Schizosaccharomyces pombe Proteins , beta-Glucans , Amino Acid Sequence , Base Sequence , Benzofurans/toxicity , Blotting, Western , Chromosomes, Fungal , Cloning, Molecular/methods , DNA, Fungal/isolation & purification , DNA, Fungal/metabolism , Fungal Proteins/genetics , Fungal Proteins/isolation & purification , Glucosyltransferases/metabolism , Hydrolases/toxicity , Killer Factors, Yeast , Kinetics , Molecular Sequence Data , Molecular Weight , Open Reading Frames , Pichia/metabolism , Protein Biosynthesis , Proteins/toxicity , Recombinant Proteins/biosynthesis , Recombinant Proteins/isolation & purification , Restriction Mapping , Saccharomyces cerevisiae/drug effects , Sequence Homology, Amino Acid , Transcription Factors
SELECTION OF CITATIONS
SEARCH DETAIL
...